4967 — Kobayashi Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥541bn
- ¥477bn
- ¥166bn
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows
Table: Kobayashi Pharmaceutical -Q1 group results
Table: Kobayashi Pharmaceutical -2025 group results
Table: Kobayashi Pharmaceutical -2025 parent forecast
Table: Kobayashi Pharmaceutical -2025 group forecast
Brief: Oasis Urges Kobayashi Pharma Shareholders To Vote Against Re-Nomination Of Akihiro Kobayashi And Yoshiro Katae
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 13.06% From 10.10%, Filing Shows
Table: Kobayashi Pharmaceutical - 9-MTH group results
Table: Kobayashi Pharmaceutical - 6-MTH group results
Table: Kobayashi Pharmaceutical -Q1 group results
Received Notice Of Lawsuit Filing From Shareholder Oasis Japan Strategic Fund
Brief: Oasis Management - Filed Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
Brief: Oasis: Urges Shareholders To Vote Against Appointment Of Akihiro Kobayashi, Others As Directors At Kobayashi Pharma AGM
Table: Kobayashi Pharmaceutical -2024 group results
Brief: Oasis: Initiates Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
Will Dismiss Shareholders' Demand To Hold Board Members Responsible For Losses Related Tainted Supplement Issue